Business Description
MediWound Ltd
NAICS : 541714
SIC : 2836
ISIN : IL0011316309
Total Employee Number:
121Description
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.49 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | -0.34 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.91 | |||||
Beneish M-Score | -3.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -34.5 | |||||
3-Year EBITDA Growth Rate | 19.8 | |||||
3-Year EPS without NRI Growth Rate | 5.1 | |||||
3-Year FCF Growth Rate | 8.7 | |||||
3-Year Book Growth Rate | 31.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.48 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 42.77 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.51 | |||||
9-Day RSI | 60.1 | |||||
14-Day RSI | 54.41 | |||||
3-1 Month Momentum % | -18.14 | |||||
6-1 Month Momentum % | -25.3 | |||||
12-1 Month Momentum % | -28.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.41 | |||||
Quick Ratio | 2.19 | |||||
Cash Ratio | 2.06 | |||||
Days Inventory | 129.78 | |||||
Days Sales Outstanding | 112.85 | |||||
Days Payable | 190.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21 | |||||
Shareholder Yield % | -0.88 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 19.61 | |||||
Operating Margin % | -193.62 | |||||
Net Margin % | -180.3 | |||||
EBITDA Margin % | -167.17 | |||||
FCF Margin % | -173.57 | |||||
OCF Margin % | -129.6 | |||||
ROE % | -69.95 | |||||
ROA % | -32.9 | |||||
ROIC % | -71.65 | |||||
3-Year ROIIC % | -51.04 | |||||
ROC (Joel Greenblatt) % | -106.65 | |||||
ROCE % | -47.92 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 11.84 | |||||
PB Ratio | 4.7 | |||||
Price-to-Tangible-Book | 4.71 | |||||
EV-to-EBIT | -6.07 | |||||
EV-to-EBITDA | -6.54 | |||||
EV-to-Revenue | 10.93 | |||||
EV-to-Forward-Revenue | 6.65 | |||||
EV-to-FCF | -6.3 | |||||
Price-to-GF-Value | 1.22 | |||||
Price-to-Median-PS-Value | 1.48 | |||||
| Price-to-Net-Current-Asset-Value | 14.3 | |||||
| Price-to-Net-Cash | 32.26 | |||||
Earnings Yield (Greenblatt) % | -16.47 | |||||
FCF Yield % | -12.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MDWD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MediWound Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 14.479 | ||
| EPS (TTM) ($) | -2.26 | ||
| Beta | 0.2447 | ||
| 3-Year Sharpe Ratio | 0.36 | ||
| 3-Year Sortino Ratio | 0.63 | ||
| Volatility % | 21.26 | ||
| 14-Day RSI | 54.41 | ||
| 14-Day ATR ($) | 0.600734 | ||
| 20-Day SMA ($) | 14.40025 | ||
| 12-1 Month Momentum % | -28.03 | ||
| 52-Week Range ($) | 13.54 - 21.255 | ||
| Shares Outstanding (Mil) | 12.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MediWound Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MediWound Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-20 08:30 | In 138 days | ||
| Third quarter earnings results for 2026 | 2026-11-20 | In 137 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 08:30 | In 40 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 39 days | ||
| First quarter earnings conference call for 2026 | 2026-05-27 08:30 | 16.68 (+0.18%) | ||
| First quarter earnings results for 2026 | 2026-05-27 | 16.68 (+0.18%) | ||
| General meeting for 2026 | 2026-05-06 10:00 | 17.44 (+1.04%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-05 08:30 | 17.60 (+3.04%) | ||
| Annual report for 2025 | 2026-03-05 | 17.60 (+3.04%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-05 | 17.60 (+3.04%) |
Show
Entries
MediWound Ltd Frequently Asked Questions
What is MediWound Ltd(MDWD)'s stock price today?
The current price of MDWD is $15.16. The 52 week high of MDWD is $21.26 and 52 week low is $13.54.
When is next earnings date of MediWound Ltd(MDWD)?
The next earnings date of MediWound Ltd(MDWD) is 2026-08-14 Est..
Does MediWound Ltd(MDWD) pay dividends? If so, how much?
MediWound Ltd(MDWD) does not pay dividend.
Guru Commentaries on NAS:MDWD
No articles.
Press Release
Articles on MediWound Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers